title: Conversion of cyclosporine to tacrolimus for refractory or persistent myocardial rejection.
authors.affiliation: Division of Cardiovascular Medicine, Stanford University School of Medicine, Falk CVRC, 300 Pasteur Drive, Stanford, CA 94305-5406, USA. chanmcy@stanford.edu
authors.forename: Michael C Y
authors.initials: MC
authors.lastname: Chan
authors.forename: B W
authors.initials: BW
authors.lastname: Kwok
authors.forename: N
authors.initials: N
authors.lastname: Shiba
authors.forename: B
authors.initials: B
authors.lastname: Cantin
authors.forename: H A
authors.initials: HA
authors.lastname: Valantine
authors.forename: S A
authors.initials: SA
authors.lastname: Hunt
mesh_terms: D001794:Blood Pressure; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D012008:Recurrence; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D002784:Cholesterol; D003404:Creatinine; D016559:Tacrolimus